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infiltration. CRAMP-deficient mice displayed a higher degree 
of glial cell activation that was accompanied by a more pro-
nounced proinflammatory response. Taken together, this 
work provides insight into the important role of CRAMP as 
part of the innate immune defense against pathogens in 
bacterial CNS infections.  © 2013 S. Karger AG, Basel 
 Introduction 
 Bacterial meningitis is a neurological emergency that 
is still associated with a high mortality rate and long-term 
sequelae.  Streptococcus pneumoniae is the leading cause 
of meningitis in adults  [1–3] . Despite advances in medical 
management, childhood vaccination and the develop-
ment of effective antimicrobial agents, mortality ranges 
from 16 to 37%  [4] , and 1 of 3 survivors suffer from neu-
rological sequelae such as epileptic seizures, hearing loss, 
cognitive impairment and focal neurological deficits  [5, 
6] . Therefore, advances in its treatment are urgently 
needed. During the past decades, experimental animal 
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 Abstract 
 Antimicrobial peptides (AP) are important components of 
the innate immune system, yet little is known about their 
expression and function in the brain. Our previous work re-
vealed upregulated gene expression of cathelicidin-related 
AP (CRAMP) following bacterial meningitis in primary rat gli-
al cells as well as bactericidal activity against frequent men-
ingitis-causing bacteria. However, the effect of cathelicidin 
expression on the progression of inflammation and mortal-
ity in bacterial meningitis remains unknown. Therefore, we 
used CRAMP-deficient mice to investigate the effect of 
CRAMP on bacterial growth, inflammatory responses and 
mortality in meningitis. Meningitis was induced by intrace-
rebral injection of type 3  Streptococcus pneumoniae . The de-
gree of inflammation was analyzed in various brain regions 
by means of immunohistochemistry and real-time RT-PCR. 
CRAMP deficiency led to a higher mortality rate that was as-
sociated with increased bacterial titers in the cerebellum, 
blood and spleen as well as decreased meningeal neutrophil 
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models have shown that the outcome of bacterial menin-
gitis is related to the severity of inflammation in the sub-
arachnoid space. This reaction is characterized by an in-
tensive inflammatory response of the meninges and the 
subarachnoid space which results in a breakdown of the 
blood-brain barrier. Consequently, large numbers of 
neutrophils are recruited to the cerebrospinal fluid, which 
liberate proinflammatory and chemotactic agents, there-
by exaggerating and perpetuating the inflammatory reac-
tion. Among the factors released by neutrophils are nu-
merous cytotoxic agents such as oxidants that can cause 
collateral damage of the brain tissue  [7] .
 Glial cells such as astrocytes and microglia are also in-
volved in pathogen recognition and the activation of in-
nate immune responses. They are the key regulators of 
innate immune responses within the brain because of their 
ability to release various factors supporting the immune 
defense of the host and helping to coordinate the activa-
tion of different immune cells  [8] . Astrocytes are further-
more required for structural support and the maintenance 
of the blood-brain barrier. Microglial cells are considered 
to be CNS-resident macrophages and sensor cells that 
function as principal innate immune effector cells  [9] .
 The activation of the innate immune system of the CNS 
leads to the synthesis of antimicrobial peptides (AP)  [10] , 
which have distinct anti-infective and proinflammatory 
properties  [11] . Our own previous investigations revealed 
increased levels of the AP cathelicidin LL-37 and psoriasin 
in the cerebrospinal fluid of patients suffering from bacte-
rial meningitis  [12, 13] . In humans, one gene is known for 
cathelicidin. The mature peptide LL-37 is cleaved from a 
precursor peptide  [14] . Furthermore, bacterial infection 
and the stimulation of glial cells by bacterial supernatants 
and virulence factors resulted in increased expression of 
the rat cathelicidin-related AP (CRAMP) by astrocytes 
and microglia as well as meningeal cells in vivo and in vi-
tro  [12, 15] . CRAMP and rat CRAMP are the active pep-
tides from the only known cath elicidin gene present in 
mice  [16] and rats  [17] , respectively.
 This study was designed to determine the role of 
CRAMP in inflammation and mortality in a mouse mod-
el of pneumococcal meningitis. We determined bacterial 
growth and mortality of infected CRAMP-deficient and 
wild-type (WT) mice and characterized the inflammatory 
response by evaluating neutrophil infiltration, glial cell 
activation and cytokine/chemokine expression by means 
of immunohistochemistry and real-time RT-PCR. Fur-
thermore, basal gene expression of inflammatory candi-
dates was determined by PCR array analysis in CRAMP-
deficient and WT mice.
 Materials and Methods 
 Mouse Model of Experimental Pneumococcal Meningitis  [18] 
 Male CRAMP-WT and CRAMP-deficient (knockout, KO) mice 
(weight 19–23 g, age 2–3 months; CRAMP-WT mice were back-
crossed on the C57BL/6J background for at least 10 generations 
 [19] ) were anesthetized with ketamine (100 mg/kg) and xylazine (20 
mg/kg), infected by injecting 10 4 colony-forming units (CFU) of an 
 S. pneumoniae  type 3 strain in the subarachnoid space through the 
right frontolateral skull. Control animals without infection were in-
jected with 10 μl of a sterile saline solution. All infected mice devel-
oped clinical signs of infection within 24 h. The clinical state and 
survival time was closely monitored. In a second set of experiments 
with the same infection regime, male CRAMP-KO and -WT mice 
were infected and sacrificed 36 h after induction of meningitis with-
out treatment with antibiotics and were either perfused with 4% 
formalin for immunohistochemical analysis or with 0.9% NaCl so-
lution for RNA isolation. Bacterial titers were evaluated 36 h after 
infection in tissue homogenates of the cerebellum and spleen and in 
blood samples by plating 10-fold dilutions on blood agar plates and 
incubation for 24 h at 37  °  C with 5% CO 2 (detection limit 10 2 CFU/
ml in tissue homogenates and 10 3 CFU/ml in blood samples)  [20] . 
All animal experiments were approved by the Animal Care Com-
mittee of the University Hospital of Aachen and by the District Gov-
ernment in Recklinghausen, North Rhine-Westphalia, Germany.
 Meningeal Inflammation Score 
 Meningeal inflammation was estimated by the invasion of 
granulocytes into the frontal interhemispheric region, the whole 
hippocampal fissure (both sides), 3 superficial meningeal regions 
over the convexities and the third ventricle (complete distribu-
tion). One high-power field (diameter: 250 mm) was scored in 
each region: no granulocytes = 0; <10 granulocytes = 1; 10–50 
granulocytes = 2, and >50 granulocytes = 3. The scores of the in-
dividual regions were added (range of the score: 0–21)  [21] .
 RNA Isolation and Real-Time RT-PCR and PCR Array 
 Total RNA was isolated using the peqGold Trifast reagent 
(Peqlab, Erlangen, Germany) according to the manufacturer’s in-
structions. RNA samples were reverse transcribed by Moloney 
murine leukemia virus reverse transcriptase (Fermentas, Burling-
ton, Ont., Canada) and random hexamer primers (Invitrogen, 
Darmstadt, Germany). The cDNA products were used immedi-
ately for SYBR green (Applied Biosystems, Darmstadt, Germany) 
real-time RT-PCR. Gene expression was monitored using the 
 StepOne Plus apparatus (Applied Biosystems) according to man-
ufacturer’s protocol  [22] . Relative quantification was performed 
using the ΔCt method which results in ratios between target genes 
and a housekeeping reference gene (TATA box binding protein). 
The primer for glial fibrillary acid protein (GFAP), integrin α M 
(Itgam) and β-defensin 4 (Defb4) were provided by Qiagen 
(QT00101143, QT00156471 and QT00257656; QuantiTect Primer 
Assay; Qiagen, Hilden, Germany). The primers for caspase-1, cas-
pase-4, interleukin (IL)-1β, IL-6 and tumor necrosis factor-α 
(TNF-α) were manufactured by Eurofins MWG Operon (Ebers-
berg, Germany; please refer to  table 1 for primer sequences). The 
specificity of the amplification reaction was determined by melting 
curve analysis. For PCR array analysis, we used the RT2 Profiler 
PCR Array Mouse Innate and Adaptive Immune Response 




















   
   
   
   
   
   
   
   
   
   
   

























 Formalin-fixed and paraffin-embedded 5-μm whole coronary 
brain sections were examined. For immunofluorescence staining, 
sections were deparaffinized, pretreated for 3 × 7 min with micro-
waves in citric acid buffer, permeabilized with 0.1% Triton X in 
PBS for 10 min at room temperature and after blocking with 1.5% 
BSA in Tris incubated with either monoclonal mouse anti-GFAP 
(1: 250; ab10062; Abcam, Cambridge, UK) or polyclonal goat anti-
ionized calcium binding adaptor molecule 1 (Iba1; 1: 100; ab5076; 
Abcam) overnight at 4   °   C. This was followed by incubation with 
the biotinylated secondary antibody (1: 400; DAKO, Hamburg, 
Germany) and peroxidase-labeled streptavidin-biotin staining. 
For staining, aminoethyl carbazole was used. After counterstain-
ing with hematoxylin, the slides were finally mounted with Aqua-
tex (Boehringer, Mannheim, Germany). For neutrophil granulo-
cyte staining, slices were stained with naphthol AS-D chloroace-
tate esterase (91-C Kit, Sigma-Aldrich, Taufkirchen, Germany) 
according to the manufacturer’s protocol. As a negative control, 
primary antibodies were omitted.
 Quantification of Immunoreactive Cells 
 Sections were examined blinded using objectives from ×2 up to 
×60. Only immunoreactive cells within the granule cell layer and 
subgranular zone of the dentate gyrus were counted. An analysis 
software imaging system (microscope BX51; Olympus; software 
AnalySIS 3.2; Soft Imaging System GmbH, Münster, Germany) 
was used to measure the area of the dentate granule cell layer. The 
densities of immunolabeled cells were expressed as the number of 
marked cells per square millimeter of the area measured. The den-
sity of labeled cells was evaluated in 3 coronal sections from each 
mouse. Immunohistochemical data were expressed as medians 
and interquartile ranges. For statistical comparisons, the nonpara-
metric Mann-Whitney U test was used.
 Statistical Analysis 
 Survival time was expressed in hours and evaluated by generat-
ing a Kaplan-Meier plot that was statistically analyzed using the 
log-rank test. Bacterial titers were converted into log CFU/ml and 
compared by nonparametric U test. All real-time RT-PCR experi-
ments were performed in duplicate. The values were expressed as 
means ± SEM. For statistical comparisons, ANOVA followed by a 
Bonferroni multiple comparison test was used. A value of p < 0.05 
was considered statistically significant. For statistical calculation, 
GraphPad Prism 5.0 was used (GraphPad Software, San Diego, 
Calif., USA).
 Results 
 CRAMP Deficiency Resulted in Increased Bacterial 
Burden, Decreased Neutrophil Infiltration and 
Increased Mortality in Pneumococcal Meningitis 
 In a first set of experiments, mortality in pneumococ-
cal meningitis was investigated. The survival time after 
infection was significantly shorter in CRAMP-deficient 
(KO) compared to WT mice (47.1 ± 8.8 vs. 68.6 ± 10.3 h, 
p = 0.0001; Mann-Whitney U test;  fig. 1 a). Fifty hours af-
ter infection, 94.1% of the WT animals were still alive 
compared to 33.3% of CRAMP-KO mice ( fig. 1 b). In ad-
dition, we determined bacterial titers in homogenates of 
the cerebellum and spleen and in blood samples from 
a separate set of CRAMP-KO and -WT mice 36 h after 
infection (no treatment with antibiotics). The results 
showed that CRAMP-KO animals had a statistically sig-
nificantly higher bacterial burden in all investigated tis-
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sue compartments compared to WT mice ( table 2 ). Fur-
thermore, neutrophil granulocyte invasion was histo-
chemically evaluated by chloroacetate esterase staining. 
Forty-eight hours after infection, WT mice displayed a 
higher degree of neutrophil granulocyte infiltration than 
CRAMP-deficient mice ( fig.  1 c). To verify the results, 
meningeal inflammation was determined by a semiquan-
titative score: a strong granulocytic invasion of the me-
ninges was observed in all infected mice 48 h after inocu-
lation, whereas infiltration of granulocytes was absent in 
noninfected animals. For CRAMP-WT mice, the menin-
geal inflammation score was 14 ± 1.6 (n = 6), whereas for 
CRAMP-KO mice the score was 9 ± 2.5 (n = 6). The dif-
ference between infected CRAMP-KO and -WT mice was 
significant (p = 0.0357, Mann-Whitney U test).


















































 Fig. 1. Mortality in pneumococcal menin-
gitis. CRAMP-WT and CRAMP-KO mice 
were infected by injection of 10 4 CFU of 
type 3 S. pneumoniae  in the subarachnoid 
space .  a Comparison of survival times re-
vealed that CRAMP-WT mice lived sig-
nificantly longer (CRAMP-WT, n = 17; 
CRAMP-KO, n = 13; medians and ranges; 
 * * *   p = 0.0001; Mann-Whitney U test). 
 b Mortality was significantly increased 
in CRAMP-KO animals (Kaplan-Meier 
curve; p = 0.0001, log-rank test).  c De-
tection of neutrophil granulocytes by 
the naphthol AS-D chloroacetate esterase 
reaction in the meninges and parenchy-
ma revealing neutrophil infiltration in 
CRAMP-WT and -KO mice 48 h after 
pneumococcal infection. The figures show 
representative results from 1 of 3 mice per 















Table 2.  Bacterial titers after pneumococcal meningitis
 Bacterial titer, log CFU/ml
c erebellum blood spleen
CRAMP-WT 5.7 (5.1/6.2) 4.28 (3.8/5.39) 4.92 (2.9/5.2)
CRAMP-KO 6.54 (6/7.5)* 6 (5.1/7)* 5.5 (5.1/6)*
 Data are presented as medians (25th/75th percentiles). Please 
note significantly increased bacterial titers in infected CRAMP-
KO compared to infected CRAMP-WT mice. n = 8/group; * p = 





















   
   
   
   
   
   
   
   
   
   
   




































 Increased Glial Cell Activation following 
Pneumococcal Meningitis in CRAMP-Deficient Mice 
 Thirty-six hours after infection, the degree of glial cell 
activation was determined by staining with GFAP, a mark-
er of astrocytes, and Iba-1, a marker for activated microg-
lia, in the hippocampal formation as a clearly definable 
brain region especially involved in the pathogenesis of bac-
terial meningitis. As shown in  figure 2 , the hippocampal 
formation of noninfected WT mice showed only very few 
GFAP- or Iba-1-positive cells, whereas infection with  S. 
pneumoniae resulted – as expected – in a strong increase 













 Fig. 2. Glial cell activation in the hippo-
campus after pneumococcal meningitis. 
Coronal brain sections stained with anti-
GFAP to discover astrocytes ( a ) or anti-
Iba-1 to identify activated microglial cells 
( b ) 36 h after infection with  S. pneumoniae. 
The figures show representative results 
from 1 of 3 independent experiments (scale 
bar = 100 μm). A detailed section was 
 included. Please note that noninfected 
CRAMP-KO mice showed a stronger en-
dogenous GFAP and Iba-1 immunoreac-
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Interestingly, healthy CRAMP-KO mice already displayed 
a high basal rate of GFAP-positive cells in the hippocampal 
formation in comparison to CRAMP-WT animals. Quan-
tification of astrocytes in the sub granular zone and the 
granule cell layer of the dentate gyrus revealed significant-
ly more astrocytes (n/mm 2 ) in CRAMP-WT mice exposed 
to  S. pneumoniae than in  NaCl-treated WT mice [nonin-
fected CRAMP-WT 1.24 (0.13/1.75)/mm 2 vs. infected WT 
7.65 (6.88/11.81)/mm 2 ; medians (25th/75th percentiles), 
Mann-Whitney U test, p = 0.0022;  fig. 3 a]. Induction of 
bacterial infection in the CRAMP-KO mice did not result 
in a significant increase in GFAP-immunoreactive cells in 
comparison to noninfected CRAMP-KO [noninfected 
CRAMP-KO 0.87 (0.63/1.5)/mm 2 vs. infected KO 1.9 
(1.38/2.29)/mm 2 ; medians (25th/75th percentiles), Mann-
Whitney U test, p = 0.067;  fig.  3 a]. Next, the density of 
GFAP-immunoreactive cells of the dentate gyrus of infect-
ed CRAMP-KO mice was normalized to infected WT 
mice. Previously, basal expression of astrocytes of unin-
fected mice was subtracted. The results showed no signifi-
cant difference between infected WT and infected CRAMP-
KO mice [2.01 (0.84/2.88)-fold increase; median (25th/
75th percentile), p = 0.3810, Mann-Whitney U test;  fig. 3 b].
 Similarly to astrocytes, the noninfected CRAMP-KO 
mice had already a higher basal rate of microglial cell ac-
tivation within the hippocampal formation in compari-
son to WT mice ( fig. 3 a). As expected, the number of mi-
croglial cells strongly increased in WT mice in the hip-
pocampal formation 36 h after infection [noninfected 
CRAMP-WT 0.0 (0.0/2)/mm 2 vs. infected WT 2.13 
(1.85/4.09)/mm 2 ; median (25th/75th percentile), Mann-
Whitney U test, p = 0.023;  fig. 3 c]. The increase following 
infection with  S. pneumoniae  was not significant [nonin-
fected CRAMP-KO 0.99 (0.85/1.16)/mm 2 vs. infected 
CRAMP-KO 1.71 (0.94/1.53)/mm 2 ; medians (25th/75th 
percentiles), p = 0.1143, Mann-Whitney U test;  fig. 3 c]. 
However, comparing only the infected CRAMP-KO mice 
normalized to infected WT mice (basal expression of mi-
croglial cells of the uninfected mice was subtracted), the 
density of Iba-1-immunoreactive cells was significant-
ly increased in the CRAMP-deficient mice [8.34 (3.56/
13.56)-fold increase in infected CRAMP-KO mice; 
 median (25th/75th percentile), p = 0.0061;  fig. 3 d].
 We analyzed mRNA expression of GFAP (as a marker 
for activated astrocytes) as well as Itgam (or CD11b  [23] , 
as a marker of microglial cell activation) in the cerebel-
























































































































 Fig. 3. Quantification of glial cells in the 
dentate gyrus of the hippocampus after 
pneumococcal meningitis. GFAP- and Iba-
1-immunoreactive cells were quantified 
per mm 2 area of the subgranular and gran-
ule cell layer of the dentate gyrus (see re-
sults) of infected and healthy CRAMP-KO 
and -WT mice 36 h after induction of men-
ingitis. Immunoreactive cells were normal-
ized to noninfected controls and fold in-
creases are presented in the graph ( a ,  c ). 
Data from 4 mice/group are presented 
as medians with ranges/mm 2 . Density of 
GFAP ( b )- and Iba-1 ( d )-immunoreactive 
cells within the subgranular and granule 
cell layer of the dentate gyrus of infected 
CRAMP-KO mice were normalized to in-
fected -WT mice. Previously, basal expres-
sion of astrocytes or microglial cells of the 
uninfected mice was subtracted. Compari-
son revealed significantly more activated 
microglia in CRAMP-KO mice in pneu-
mococcal meningitis ( *  p < 0.05, * *   p = 
0.0061, infected vs. noninfected mice, 
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lum, hippocampal formation, brain stem and frontal cor-
tex of CRAMP-KO and -WT mice 36 h after infection 
with  S. pneumoniae . As shown in  figure 4 a–d, WT mice 
showed a significant increase in GFAP mRNA expression 
in the cerebellum, hippocampal formation and frontal 
cortex (11.2 ± 3, 7.8 ± 1.7 and 7.2 ± 2.1 times, respective-
ly; all p < 0.05;  fig. 4 a, b, d), whereas no significant in-
crease in GFAP mRNA expression was detected in any 
region of CRAMP-KO mice. In WT mice, Itgam mRNA 
expression was only significantly increased in the cerebel-
lum (7.5 ± 1.4 times, p < 0.05;  fig. 4 e), whereas CRAMP-
deficient mice showed a significant increase in activated 
microglial cell gene expression in the cerebellum, hippo-
campus and brain stem (11.4 ± 3.1, 8 ± 2.9 and 12.9 ± 4.9 
times, respectively; p < 0.05;  fig. 4 e–g).
 Comparison of General Immune Response after 
Bacterial Meningitis in the Hippocampal Formation 
of CRAMP-KO and -WT Mice by PCR Array and 
Real-Time RT-PCR 
 In a next set of experiments, we analyzed mRNA ex-
pression of genes generally involved in innate and adap-
tive immune responses in the hippocampal formation 
of CRAMP-KO and -WT mice 36 h after infection with 
 S. pneumoniae . As shown in online supplementary figure 
1A (for all online supplementary material, see www. 
karger.com/doi/10.1159/000353645), 24 genes showed 
increased expression while 4 genes were downregulated 
in infected WT mice compared to noninfected WT mice. 
In 59 genes, the expression rate did not change.  Table 3 
shows the genes with a change in the expression (increase 
or decrease). However, the differences between infected 
and noninfected WT animals were not significant (n = 3). 
In CRAMP-deficient mice, infection resulted in an in-
creased expression of 33 genes, whereas the expression of 
only 1 gene was decreased. In 14 genes, mRNA expression 
was significantly increased compared to noninfected 
mice. Altogether, the results showed a stronger immune 
response in CRAMP-KO mice than -WT mice after pneu-
mococcal infection.
 To verify the results of the PCR array, we evaluated 
gene expression of candidates both in the hippocampal 
formation as well as in the cerebellum, brain stem and 
frontal cortex from CRAMP-deficient and -WT mice. 






























































































































































































































































 Fig. 4. Gene expression of glial cell markers after pneumococcal 
meningitis. Analysis of mRNA expression of the astrocyte marker 
GFAP ( a–d ) and the activated microglial marker Itgam ( e–h ) in 
the cerebellum, hippocampal formation, brain stem and frontal 
cortex of CRAMP-KO and -WT mice 36 h after induction of pneu-
mococcal meningitis by real-time RT-PCR. Data were assessed in 
6 independent experiments in duplicate.  *   p < 0.05 infected 
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First we examined gene expression of caspase-1, which 
proteolytically cleaves other precursors of inflammatory 
cytokines IL-1β and IL-18 into active mature peptides 
 [24] . As shown in  figure 5 a–d, expression analysis re-
vealed only a low but significant increase in infected WT 
mice (maximum in the cerebellum; 4.4 ± 0.7 induction 
compared to noninfected CRAMP-WT; p < 0.05) where-
as the increase in the expression in three of four brain 
regions of the CRAMP-deficient mice was statistically 
significant with a maximum increase in the frontal cortex 
Table 3.  Results of PCR array mouse innate and adaptive immune responses
Gene x-fold of control
CRA MP-WT CRAMP-KO
Adora2a (adenosine A2A receptor) 5.5895 4.4838
Casp1 (caspase-1) 4.3058 4.314*
Casp 4 (caspase-4) 22.9138 38.8959*
Ccl2 (CCL2) 106.4495 2,875.7481
Ccr3 (C-C chemokine receptor type 3) – 4.0441
Cd14 34.4855 29.3627
Clec7a (C-type lectin domain family 7 member A/dectin) – 5.7234*
Cybb (cytochrome b-245) 14.0473 29.3954*
Defb4 – 4.1689
Dmbt1 (deleted in malignant brain tumors 1) – 4.0212
Hmox1 [heme oxygenase (decycling) 1] 5.4103 5.4396
Ifnb1 (interferon-β1) 9.1583 4.0817
Il10 (IL-10) 4.4772 4.7127
Il1a (IL-1α) 11.614 14.019
Il1b (IL-1β) 52.6794 66.8595
Il1f9 (IL-1 family member 9) 24.1392 25.3921
Il1r2 (IL-1 receptor, type II) 8.5841 6.4109
Il1rn (IL-1 receptor antagonist) 6.6392 9.6017
Il6 (IL-6) 55.0987 48.4762
Irf1 (interferon regulatory factor 1) 6.3225 12.0827*
Lyz1 (lysozyme 1) 5.4183 13.1175
Myd88 [myeloid differentiation primary response gene (88)] – 6.5557*
Ncf4 (neutrophil cytosolic factor 4) 5.3611 9.4759*
Nfkbia [nuclear factor of κ light polypeptide gene enhancer in B-cells inhibitor,
alpha (http://www.genenames.org/data/hgnc_data.php?hgnc_id=7797)] 4.1035 –
Nlrc4 (NLR family CARD domain-containing protein 4) – 5.5342*
Pglyrp1 (peptidoglycan recognition protein 1) – 4.5003*
Pglyrp3 (peptidoglycan recognition protein 3) 4.4648 –
Ptafr (platelet-activating factor receptor gene) – 11.5002*
Serpine1 (plasminogen activator inhibitor-1) 18.6022 23.5001*
Tlr1 (TLR1) – 5.0086*
Tlr2 (TLR2) 7.9732 26.2452
Tlr8 (TLR8) – 6.2569*
Tlr9 (TLR9) – 4.1669
Tnf (TNF-α) 25.0953 82.921
Trem1 (triggering receptor expressed on myeloid cells 1) 7.759 8.4433
Fn1 (fibronection 1) –18.7371 –
Ifngr2 (interferon-γ receptor 2) –33.3823 –
Nos2 (nitric oxide synthase 2) –13.9407 –
Serpina1a [serine (or cysteine) peptidase inhibitor member 1A] – –4.5967
 Expression levels of different genes in the hippocampal formation of CRAMP-KO and -WT mice. Only genes 
with increased or decreased expression rates are listed. – = No change in expression. Each group represents the 
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(22.4- ± 6.6-fold induction compared to noninfected 
CRAMP-KO mice, p < 0.05 between infected CRAMP-
WT and -KO mice). Similarly, gene expression of the cys-
teine protease caspase-4 was only slightly increased by 
infection in all four brain regions in WT mice ( fig. 5 e–h; 
maximum in the cerebellum: 9.8 ± 5.1 increase in induc-
tion; nonsignificant compared to noninfected CRAMP-
WT mice), whereas in CRAMP-KO mice the expression 
increase was more pronounced with the gene expression 
rate reaching statistical significance within the brain stem 
(35.3- ± 8.2-fold increase compared to non-infected 
CRAMP-KO mice, p < 0.05 CRAMP-WT vs. -KO mice; 
 fig. 5 g). Furthermore,  table 3 shows that in the hippocam-
pal formation of CRAMP-deficient mice Defb4 expres-
sion was increased. Defb4 is the mouse homologue of the 
human Defb2  [25] . To verify the hypothesis that Defb4 
compensates the lack of CRAMP, we compared Defb4 
expression in the different brain regions of CRAMP-de-
ficient and -WT mice. While in WT mice Defb4 expres-
sion was only slightly increased in the hippocampal for-
mation and frontal cortex with maximum expression in 
the cortex (9.5- ± 2-fold increase vs. noninfected WT 
mice; p < 0.05;  fig. 5 l), CRAMP-deficient mice displayed 
a strong increase in Defb4 expression in all pathological 
Hippocampus Brain stem Cortex



























































































































































































































































































































































































 Fig. 5. Expression of different inflammation markers after pneu-
mococcal meningitis in different brain regions. 36 h after sub-
arachnoid infection with S.  pneumoniae , mRNA expression levels 
of caspase-1 ( a–d ), caspase-4 ( e–h ) and Defb4 ( i–l ) were deter-
mined in the cerebellum, hippocampal formation, brain stem and 
cortex of CRAMP-KO and -WT mice by real-time RT-PCR. Please 
note the stronger increase in expression in infected CRAMP-KO 
compared to infected-WT mice. Data were assessed in 6 indepen-
dent experiments in duplicate.  *   p < 0.05,  * *   p < 0.01, infected 
CRAMP-WT vs. infected CRAMP-KO mice (ANOVA followed 
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brain regions studied. The increase in the hippocampal 
formation was significant compared to infected WT mice 
(30.3- ± 8.5-fold increase vs. noninfected CRAMP-defi-
cient mice, p < 0.05 CRAMP-WT vs. -KO mice).
 Next, we compared the expression of the proinflam-
matory cytokines IL-1β, IL-6 and TNF-α, which play an 
important role during the course of pneumococcal men-
ingitis. The infection resulted in a strong increase in IL-1β 
mRNA expression in both strains with highest increases 
in the cerebellum and cortex of CRAMP-WT mice (24.2- 
± 10- and 30.2- ± 11-fold induction of expression vs. non-
infected WT mice, respectively; p < 0.05;  fig.  6 a–d), 
whereas the expression within the hippocampus, brain 
stem and cortex was significantly higher in CRAMP-de-
ficient mice compared with infected WT mice (52.3- ± 
19-, 97.1- ± 23- and 166- ± 68-fold increase in expression, 
p < 0.05 or p < 0.01 between infected CRAMP-WT and 
-KO mice). The expression of both IL-6 and TNF-α were 
increased in both strains but generally more pronounced 
in CRAMP-deficient mice. The maximum increase in 
both IL-6 and TNF-α mRNA expression in the WT mice 
was detected in the cortex (10.4- ± 2.2-fold induction in 
expression vs. noninfected WT mice; p < 0.01;  fig.  6 h; 
12.1- ± 4.2-fold induction in expression compared to 
noninfected WT mice; p < 0.05;  fig.  6 l). In infected 


























































































































































































































































Cerebellum Hippocampus Brain stem Cortex




















































































































a b c d
e f g h
i j k l
 Fig. 6. Expression of proinflammatory cytokines after pneumococ-
cal meningitis in different brain regions. 36 h after subarachnoid 
infection with  S. pneumoniae , mRNA expression levels of IL-1β 
( a–d ), IL-6 ( e–h ) and TNF-α ( i–l ) were determined in the cerebel-
lum, hippocampal formation, brain stem and cortex of CRAMP-
KO and -WT mice by real-time RT-PCR. Please note the stronger 
increase in expression in infected CRAMP-KO compared to in-
fected WT mice. Data were assessed in 6 independent experiments 
in duplicate.  *  p < 0.05,  * *  p < 0.01,  * * *  p < 0.001, infected CRAMP-
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pression was reached for IL-6 in the cerebellum (96.5- ± 
31.7-fold increase in expression vs. noninfected CRAMP-
KO mice, p < 0.01 between infected CRAMP-WT and 
-KO mice;  fig. 6 e) and for TNF-α in the cortex (101.7- ± 
50.4-fold increase in expression compared to noninfected 
CRAMP-KO mice, p < 0.05 between infected CRAMP-
WT and -KO mice;  fig. 6 l).
 Discussion 
 In the present study, the consequences of the lack of 
CRAMP were investigated in a very well-established and 
-characterized mouse model of pneumococcal meningitis 
 [18] . CRAMP deficiency resulted in a higher mortality 
rate that was associated with increased bacterial burden 
and decreased neutrophil granulocyte infiltration in the 
CNS as well as in distinct changes in inflammatory im-
mune reactions. Our results suggest that CRAMP is an 
important component of innate immune responses in the 
defense of the CNS against  S. pneumoniae  invasion and 
that the lack of this protein results in an unfavorable out-
come. These results are supported by other studies using 
infection models in CRAMP-deficient mice. Chromek et 
al.  [26] showed that cathelicidin protects the urinary tract 
of children against invasive bacterial infection by Esche-
richia coli and Huang et al.  [27] reported an increased 
susceptibility to  Pseudomonas aeruginosa  keratitis in 
CRAMP-deficient mice. Reduced bacterial clearance and 
delayed neutrophil influx were observed in CRAMP-KO 
mice infected with  P. aeruginosa  [28] . Mice lacking 
CRAMP were more susceptible to meningococcal infec-
tion and exhibited increased bacterial growth in the 
blood, liver, and spleen  [29] . In a previous work, we em-
phasized the importance of AP in CNS infections by re-
vealing increased synthesis of the human cathelicidin LL-
37 and S100 protein psoriasin in the cerebrospinal fluid 
of patients suffering from bacterial meningitis  [12, 13] . In 
addition, our in vitro studies revealed an increase in rat 
CRAMP in glial and meningeal cells after exposure to 
bacterial components  [12, 15] . Other work showed a di-
rect antimicrobial activity of cathelicidins against  S. pneu-
monia and  Neisseria meningitidis as the most important 
meningitis pathogens  [29, 30] . With respect to insertion 
into membrane bilayers, the cathelicidins form pores in 
the bacterial membrane which resulted in increased per-
meability with subsequent rapid cell death. A second 
mechanism for bacterial killing is the binding of intracel-
lular targets to influence bacterial proteins (e.g. the acti-
vation of autolytic enzymes, inhibition of cell wall biosyn-
thesis and synthesis of DNA, RNA and protein). Another 
important feature of these peptides is their capacity to 
bind and neutralize bacterial lipopolysaccharides in vitro, 
which may account for the ability of exogenously admin-
istered peptides to protect against sepsis in vivo  [31] . Tak-
en together, AP represent an important part of the first-
line defense against invading bacteria in the CNS such as 
the important pathogen S. pneumoniae . In addition to its 
antimicrobial activity, CRAMP also acts as a potent che-
moattractant for myeloid cells engaging FPR2 which may 
be a contributing factor to reduced neutrophil infiltration 
in CRAMP-deficient mice observed in this study  [32, 33] . 
Furthermore, CRAMP enhanced neutrophil host defense 
via an increase in IL-8 expression under the control of 
MAPK p38 and extracellular signal-regulated kinase, and 
stimulated the generation of reactive oxygen species time 
and dose dependently. Furthermore, CRAMP exhibits its 
immunoregulatory properties by stimulating IL-6 cyto-
kine production and glial cell activation and its potential 
neuroprotective properties via the induction of neuro-
trophic factors  [34, 35] .
 In general, the meningitis-induced systemic inflam-
matory reaction is dependent on the release of both bac-
terial toxins and its interaction with host pattern recogni-
tion receptors as well as host-derived cytotoxic agents. 
This physiologic process can be harmful because it results 
in the recruitment of neutrophils that are considered an 
important part of the host-derived detrimental effects by 
releasing cytotoxic agents that may lead to direct brain 
tissue damage  [7] . However, our results showed decreased 
neutrophil infiltration in infected KO mice associated 
with increased bacterial titers and an increased inflam-
matory reaction.
 Several studies have demonstrated the importance of 
glial cells in the development and regulation of inflamma-
tory reactions following the infection of the CNS or in 
neurodegenerative diseases  [36, 37] . The brain is protect-
ed from penetrating pathogens by the blood-brain bar-
rier as well as by glial cells such as astrocytes and microg-
lia. Astrocytes belong to the well-characterized innate im-
mune neuroglia, and in addition to many other roles, 
their main function is the synthesis and regulation of in-
flammatory cytokines such as IL-1ß, IL-6 and different 
chemokines  [38] as well as the synthesis of anti-inflam-
matory cytokines  [39] . The mediatory functions of astro-
cytes are compromised during inflammatory reactions 
and thereby potentially worsening outcome  [36] . Microg-
lial cells are the macrophages of the brain. Microglial cells 
are being activated after the invasion of pathogens into 
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tors such as cytokines and chemokines to activate other 
immune cells. They can also function as antigen-present-
ing cells in the brain for invading immune cells such as T 
lymphocytes  [9] . In bacterial meningitis, increased acti-
vation of astrocytes and microglia may aggravate neuro-
nal cell death in the hippocampal formation by both in-
duction of apoptosis and necrosis  [40] . However, our 
findings revealed a strong increase in the astrocyte mark-
er GFAP in infected WT mice, whereas the CRAMP-de-
ficient animals displayed an already increased basal rate 
of astrocyte activation with only small further increase 
under pathological conditions. Comparison of infected 
CRAMP-deficient and -WT mice revealed that the den-
sity of GFAP-immunoreactive cells was about the same in 
both groups. This shows that CRAMP deficiency results 
per se in a higher activation state of astrocytes whose ex-
tent is comparable to that of ‘physiological inflammation’ 
after bacterial invasion. Similar results were obtained for 
microglial activation in healthy animals: CRAMP defi-
ciency alone resulted in a higher degree of Iba-1 immu-
noreactivity in comparison to noninfected controls. In 
contrast to the observations of astrocytes, the density of 
Iba-1-positive cells/Itgam gene expression of infected 
CRAMP-deficient mice was significantly higher than in 
WT mice suggesting enhanced microglial activation by 
CRAMP deficiency after pneumococcal meningitis. The 
observation of enhanced endogenous glial cell activation 
in CRAMP-deficient mice in comparison to WT mice 
was not published in other studies yet and therefore 
needs further investigation.
 The hippocampal formation is one of the most vulner-
able brain regions in general and in bacterial meningitis 
in particular. Neuronal damage within the dentate gyrus 
is due to both bacteremia and inflammatory reactions 
and closely related to long-term sequelae, such as memo-
ry impairment  [41, 42] . Therefore, we compared the gen-
eral immune response after pneumococcal meningitis be-
tween CRAMP-deficient and -WT mice. Using a PCR 
 array for markers of innate and adaptive immune re-
sponses, we found increased expression of the pattern 
recognition receptors Toll-like receptors (TLR) 1, 2, 8 and 
9 in the hippocampal formation of infected CRAMP-de-
ficient mice. TLR play a major role in triggering the im-
mune response. They are able to detect a variety of patho-
gens and initiate inflammatory immune responses  [9] . 
Interestingly, TLR1 and TLR2 are involved in the detec-
tion of components of Gram-positive bacteria such as  S. 
pneumoniae while TLR8 and TLR9 are responsible for the 
detection of ssRNA and dsDNA from various pathogens 
 [43] . Previous findings suggest an involvement of TLR9 
in innate immune responses after pneumococcal menin-
gitis by influencing CRAMP expression in mice  [44] . In 
addition, an important signaling protein of the TLR path-
ways, the adapter protein MyD88, was increased only in 
the infected CRAMP-deficient mice. The increase in TLR 
receptor expression was accompanied by an increase in 
proinflammatory cytokine expression. Recent studies un-
derlined the importance of TNF-α, for example, for in-
flammatory processes  [45] , but also for neuronal apopto-
sis in the hippocampus  [46] . The higher expression rate 
of TNF-α in infected CRAMP-deficient mice may be re-
garded as the expression of a stronger immune reaction 
in those animals and may have influenced or even caused 
the worse outcome in the form of higher mortality. The 
generally stronger inflammatory response was also ac-
companied by increased expression of caspase-1 and -4. 
As a third class of caspases, they are involved in inflam-
mation  [47] . After the recognition of pathogens, cas-
pase-1 molecules group together to form an oligomeric 
inflammasome  [48] . The activated caspase-1 is now able 
to process proIL-1β and is thereby involved in immune 
responses  [24] . Our findings showed a strong increase of 
IL-1β expression in infected CRAMP-deficient compared 
to the -WT mice associated with increased caspase-1 
 expression. Furthermore, caspase-4 – as well as cas-
pase-1 – has immunomodulatory effects. It is believed 
that caspase-4 is required to splice caspase-1 and thus to 
activate it  [49] . Taken together, all these changes in the 
inflammatory reaction caused by CRAMP deficiency ac-
companied the unfavorable outcome. However, it cannot 
be concluded from these data whether all these changes 
in the inflammatory cascade are only caused by the lack 
of CRAMP alone or whether the higher bacterial burden 
may also in part be responsible for these changes.
 Interestingly, the PCR array and real-time RT-PCR re-
vealed increased expression of the AP Defb4 in infected 
CRAMP-KO mice. Mouse Defb4 is the homologue of the 
human β-defensin 2  [25] . Defb4 acts synergistically with 
antimicrobial lysozyme against bacteria  [50] . Lysozyme is 
an enzyme which hydrolyses the sugar backbone of pep-
tidoglycans in the cell wall of Gram-positive bacteria and 
thus disassembles the highly immunogenic peptidogly-
can into less inflammable components  [51] . In patients 
suffering from pneumococcal meningitis, the amount of 
lysozyme is increased  [52] . Our results showed a stronger 
increase in infected CRAMP-deficient compared to -WT 
mice. We propose that by increasing Defb4 expression, 
the lack of CRAMP may be compensated. The lack of 
CRAMP resulted in an increased number of bacteria and 
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consequence of the imbalance in the innate immune sys-
tem due to the lack of CRAMP which results in an imbal-
ance in pro- and anti-inflammatory mediators. It can be 
hypothesized that CRAMP physiologically exerts anti-in-
flammatory effects. Additional studies need to explore 
this topic in further detail.
 In conclusion, our results reveal the importance of the 
CRAMP in host defense in a mouse model of pneumo-
coccal meningitis. Although pneumococci are pathogens 
for rodents  [18, 53] , the immune response in the mouse 
is partly different from the immune response in humans 
 [54] . These limitations must be considered in the inter-
pretation of the results. However, despite these limita-
tions, our results provide interesting insights into the 
function of the innate immune system in the course of 
bacterial meningitis. A balanced immune response in-
cludes the presence of soluble components of innate im-
munity such as AP. Thus, the lack of APs leads to greater 
damage and increased mortality. As a next step, adjunc-
tive treatment of bacterial meningitis with CRAMP will 
help to evaluate the potential therapeutic use of these pep-
tides in bacterial infections.
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In the article by Merres et al., entitled ‘Role of the cathelicidin-related antimicrobial pep-
tide in inflammation and mortality in a mouse model of bacterial meningitis’ [J Innate 
Immun 2014;6:205–218, DOI: 10.1159/000353645], the authors’ contributions footnote 
should correctly read ‘J.M. and J.H. contributed equally as first authors; S.C.T. and L.-O.B. 
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